iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionBeacon Investment Advisory Services, Inc.
Latest Disclosed Ownership2,150 shares
Latest Disclosed Value $ 363,028
Beacon Investment Advisory Services, Inc. ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On April 14, 2026 - Beacon Investment Advisory Services, Inc. filed a 13F-HR form disclosing ownership of 2,150 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $363,028 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on January 16, 2026 disclosing 2,150 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $281,758 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,150 0 0.00 363 0.28 0.0149
2026-01-16 2025-12-31 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 2,150 -52 -2.36 363 14.20 0.0148
2026-01-14 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,150 -52 363 0.0148
2025-10-16 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,202 52 2.42 318 16.97 0.0134
2025-07-15 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,150 0 0.00 272 -1.09 0.0120
2025-05-06 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,150 0 0.00 275 -3.52 0.0129
2025-01-17 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,150 -200 -8.51 284 -16.96 0.0123
2024-11-14 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,350 -300 -11.32 342 -5.79 0.0142
2024-08-14 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,650 0 0.00 364 0.00 0.0156
2024-05-09 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,650 0 0.00 364 0.83 0.0157
2024-02-12 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,650 0 0.00 360 11.11 0.0164
2023-10-31 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,650 -277 -9.46 324 -12.67 0.0160
2023-07-21 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,927 75 2.63 372 0.82 0.0171
2023-05-04 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,852 -205 -6.71 368 -8.23 0.0179
2023-01-13 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,057 0 0.00 401 12.01 0.0206
2022-10-20 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,057 -400 -11.57 358 -12.04 0.0197
2022-07-21 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,457 0 0.00 407 -9.56 0.0212
2022-05-12 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,457 0 0.00 450 -14.77 0.0192
2022-02-04 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,457 0 0.00 528 -5.55 0.0205
2021-11-09 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,457 0 0.00 559 -1.24 0.0231
2021-08-02 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,457 201 6.17 566 15.51 0.0229
2021-05-21 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,256 0 0.00 490 -0.61 0.0214
2021-02-08 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,256 400 14.01 493 27.39 0.0228
2020-10-29 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,856 0 0.00 387 -0.77 0.0201
2020-07-28 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,856 0 0.00 390 26.62 0.0222
2020-05-05 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,856 0 0.00 308 -10.47 0.0217
2020-01-31 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,856 -100 -3.38 344 17.01 0.0183
2019-10-29 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,956 0 0.00 294 -8.70 0.0294
2019-08-07 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,956 0 0.00 322 -2.42 0.0341
2019-05-15 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,956 2,956 330 0.0350
2019-02-07 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -2,050 -100.00 0 -100.00
2018-11-08 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,050 -50 -2.38 250 8.23 0.0243
2018-08-08 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,100 135 6.87 231 10.00 0.0234
2018-04-26 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 1,965 -60 -2.96 210 -2.78 0.0217
2018-04-26 2017-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 2,025 1,336 193.90 216 -6.09 0.0228
2018-02-02 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,025 1,336 216 0.0228
2017-11-14 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 689 689 230 0.0197
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.